Aplisol - 42023-104-05 - (tuberculin purified protein derivative)

Alphabetical Index


Drug Information of Aplisol

Product NDC: 42023-104
Proprietary Name: Aplisol
Non Proprietary Name: tuberculin purified protein derivative
Active Ingredient(s): 5    [iU]/.1mL & nbsp;   tuberculin purified protein derivative
Administration Route(s): INTRADERMAL
Dosage Form(s): INJECTION
Coding System: National Drug Codes(NDC)

Labeler Information of Aplisol

Product NDC: 42023-104
Labeler Name: JHP Pharmaceuticals LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA001781
Marketing Category: BLA
Start Marketing Date: 20080207

Package Information of Aplisol

Package NDC: 42023-104-05
Package Description: 5 mL in 1 VIAL (42023-104-05)

NDC Information of Aplisol

NDC Code 42023-104-05
Proprietary Name Aplisol
Package Description 5 mL in 1 VIAL (42023-104-05)
Product NDC 42023-104
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name tuberculin purified protein derivative
Dosage Form Name INJECTION
Route Name INTRADERMAL
Start Marketing Date 20080207
Marketing Category Name BLA
Labeler Name JHP Pharmaceuticals LLC
Substance Name TUBERCULIN PURIFIED PROTEIN DERIVATIVE
Strength Number 5
Strength Unit [iU]/.1mL
Pharmaceutical Classes Skin Test Antigen [EPC],Tuberculosis Skin Test [EPC],Cell-mediated Immunity [PE],Antigens, Bacterial [Chemical/Ingredient]

Complete Information of Aplisol


General Information